What are NADPH oxidase 2 inhibitor drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NADPH oxidase 2 inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting NOX2). 0 are currently marketed, with 2 more in clinical development.

NADPH oxidase 2 inhibitor

0 marketed 2 in Phase 2

This page covers all NADPH oxidase 2 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NOX2.

Targets

NOX2

Phase 2 pipeline (2)

CTX-4430 · Celtaxsys, Inc. · Immunology
CTX-4430 is a small molecule inhibitor of the NADPH oxidase 2 (NOX2) enzyme.
BHV3241, verdiperstat · Biohaven Pharmaceuticals, Inc. · Neurology
BHV3241, also known as verdiperstat, is a small molecule inhibitor of the enzyme NADPH oxidase 2 (NOX2).

Patent intelligence

nadph oxidase 2 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates